Skip to main content

and
  1. Article

    Open Access

    p53 activation enhances the sensitivity of non-small cell lung cancer to the combination of SH003 and docetaxel by inhibiting de novo pyrimidine synthesis

    Identifying molecular biomarkers for predicting responses to anti-cancer drugs can enhance treatment precision and minimize side effects. This study investigated the novel cancer-targeting mechanism of combini...

    Yu-Jeong Choi, Kangwook Lee, Seo Yeon Lee, Youngbin Kwon in Cancer Cell International (2024)